Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Episodic neonatal hypoxia evokes executive dysfunction and regionally specific alterations in markers of dopamine signaling.

Decker MJ, Hue GE, Caudle WM, Miller GW, Keating GL, Rye DB.

Neuroscience. 2003;117(2):417-25.

PMID:
12614682
2.
3.

Neonatal intermittent hypoxia impairs dopamine signaling and executive functioning.

Decker MJ, Rye DB.

Sleep Breath. 2002 Dec;6(4):205-10. Review.

PMID:
12524574
4.
5.
6.
8.

GM1 enhances dopaminergic markers in the brain of aged rats.

Goettl VM, Zhang H, Burrows AC, Wemlinger TA, Neff NH, Hadjiconstantinou M.

Exp Neurol. 2003 Oct;183(2):665-72.

PMID:
14552908
10.

Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.

Hansen JP, Riddle EL, Sandoval V, Brown JM, Gibb JW, Hanson GR, Fleckenstein AE.

J Pharmacol Exp Ther. 2002 Mar;300(3):1093-100.

12.
14.

Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.

González-Hernández T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Pérez-Delgado M, Rodríguez M.

J Comp Neurol. 2004 Nov 8;479(2):198-215.

PMID:
15452855
15.

Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes.

Amenta F, Bronzetti E, Cantalamessa F, El-Assouad D, Felici L, Ricci A, Tayebati SK.

J Neuroimmunol. 2001 Jul 2;117(1-2):133-42.

PMID:
11431013
16.

Mild intermittent hypoxia does not induce stress responses in the neonatal rat brain.

Boss V, Sola A, Wen TC, Decker MJ.

Biol Neonate. 2005;88(4):313-20. Epub 2005 Aug 18.

PMID:
16113526
17.
18.

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.

Vander Borght T, Kilbourn M, Desmond T, Kuhl D, Frey K.

Eur J Pharmacol. 1995 Dec 29;294(2-3):577-83.

PMID:
8750721
19.
20.

Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity.

Truong JG, Wilkins DG, Baudys J, Crouch DJ, Johnson-Davis KL, Gibb JW, Hanson GR, Fleckenstein AE.

J Pharmacol Exp Ther. 2005 Sep;314(3):1087-92. Epub 2005 May 18.

Supplemental Content

Support Center